GlassScriptPhysician profile
Lorna Hew
NPI 1649435207
$3,120.09
in general payments reported to CMS, 2019-2025
15 companies · $492 in 2025
The $492 reported for 2025 was more than what 76% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,090 · 2022: $705 · 2023: $383 · 2024: $449 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $717.32 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $459.12 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $398.28 | 2021-2025 | Farxiga |
| Novartis Pharmaceuticals Corporation | $363.87 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $332.65 | 2021-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $287.98 | 2021-2024 | Xarelto |
| Amgen INC. | $251.14 | 2021-2024 | Repatha |
| Cardiva Medical, INC. | $89.42 | 2022-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Cordis US Corp. | $43.14 | 2024-2025 | Mynx Control Venous, Mynx Control |
| Irhythm Technologies, INC. | $41.93 | 2024 | Zio Xt Patch, Zio Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.63 | 2023 | Jardiance |
| Atricure, INC. | $32.54 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Epi-Ease Epicardial Access System |
| Abbott Laboratories | $26.13 | 2024 | Aveir |
| Kiniksa Pharmaceuticals International, Plc | $23.94 | 2024 | Arcalyst |
| Medtronic, INC. | $18.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorna Hew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.